C. David Nicholson, Director at Actinium Pharmaceuticals, Inc. (ATNM), bought 5,000 shares at $2.00 ($10K) on 2016-04-14, disclosed to the SEC on 2016-04-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.